Visceral leishmaniasis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 9: | Line 9: | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | ||
{{SK}} Burdwan fever; | {{SK}} Burdwan fever; dumdum fever | ||
==[[Visceral leishmaniasis overview|Overview]]== | ==[[Visceral leishmaniasis overview|Overview]]== | ||
Line 19: | Line 19: | ||
==[[Visceral leishmaniasis causes|Causes]]== | ==[[Visceral leishmaniasis causes|Causes]]== | ||
==[[Visceral leishmaniasis differential diagnosis|Differentiating Visceral | ==[[Visceral leishmaniasis differential diagnosis|Differentiating Visceral Leishmaniasis from other Diseases]]== | ||
==[[Visceral leishmaniasis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Visceral leishmaniasis epidemiology and demographics|Epidemiology and Demographics]]== | ||
Line 52: | Line 52: | ||
[[Category:Parasitic diseases]] | [[Category:Parasitic diseases]] | ||
[[Category:Neglected diseases]] | [[Category:Neglected diseases]] | ||
Latest revision as of 19:09, 18 September 2017
Visceral leishmaniasis | |
Amastigotes in a chorionic villus |
Visceral leishmaniasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Visceral leishmaniasis On the Web |
American Roentgen Ray Society Images of Visceral leishmaniasis |
Risk calculators and risk factors for Visceral leishmaniasis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: Burdwan fever; dumdum fever
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Visceral Leishmaniasis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies